The impact of an educational and information systems initiative on somatic BRCA testing rates in patients with high grade serous tubo-ovarian cancer in Western Australia

OBJECTIVE: Poly-ADP ribose polymerase inhibitors (PARPi) have expanded the management armamentarium against high grade serous tubo-ovarian cancer (HGSOC) in patients with germline and somatic BRCA pathogenic variants (PVs). Germline testing has been available in Western Australia (WA) since July 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Fantoni, Andrew, Meniawy, Tarek, Cohen, Paul A., McMullen, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372359/
https://www.ncbi.nlm.nih.gov/pubmed/37520785
http://dx.doi.org/10.1016/j.gore.2023.101246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372359/
https://www.ncbi.nlm.nih.gov/pubmed/37520785
http://dx.doi.org/10.1016/j.gore.2023.101246

Ejemplares similares